Clinical Trial: Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-blind, Placebo-controlled, Randomized Study: 16-week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering Fro

Brief Summary: clinical efficacy and safety of Levetiracetam as add-on therapy in adult Chinese subjects with partial seizures.

Detailed Summary:
Sponsor: UCB Pharma

Current Primary Outcome: The partial onset (type I) seizure frequency reduction per week over the 16-week treatment period (titration and maintenance)

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Seizure freedom ;
  • The partial onset (type I) seizure reduction response rate ;
  • Safety and tolerability


Original Secondary Outcome: Same as current

Information By: UCB Pharma

Dates:
Date Received: September 7, 2005
Date Started: July 2004
Date Completion:
Last Updated: December 2, 2013
Last Verified: September 2009